Your session is about to expire
← Back to Search
Exercise Training for Blood Cancers Survivorship (S-POP Trial)
S-POP Trial Summary
This trial will investigate the effects of high-intensity interval training and resistance training on physical function, cognitive function, mental health, and quality of life in patients who have undergone hematopoietic stem cell transplant, as well as in the caregivers of these patients.
S-POP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowS-POP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.S-POP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking care of someone who has had a stem cell transplant.I had a bone marrow transplant from a donor within the last 60 to 120 days.I'm sorry, it seems like you did not complete the criteria. Could you please provide me with more information?You must be able to speak English.I am 18 years old or older.
- Group 1: Patient
- Group 2: Caregiver
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there currently an opportunity for participants to join this investigation?
"Affirmative. Based on the information housed by clinicaltrials.gov, this study is actively recruiting participants and was last modified on October 5th 2022. 70 people need to be recruited from 1 medical site for full participation in the trial."
Does this clinical trial accept patients of age 25 and up?
"According to the requirements for entry, participants must be aged between 18 and 80 in order to take part."
Are the criteria for enrolment in this trial compatible with my qualifications?
"The trial is accepting 70 adults (aged 18 to 80) with hematologic neoplasms. To be eligible, participants must meet the following conditions: speaking English fluently; having undergone allogenic HCT within 90 ± 30 days prior to enrollment; providing post-discharge care for a patient who has received HCT and being both a patient and caregiver."
How many participants are involved in the current experiment?
"Indeed, the data hosted on clinicaltrials.gov confirms that this medical investigation is recruiting volunteers as of now, having been initially advertised on November 1st 2022 and edited most recently on October 5th 2022. The study requires 70 participants to be sourced from 1 centre."
Share this study with friends
Copy Link
Messenger